A clinical study for intestinal microbiota transplantation in patients with type 2 diabetes mellitus

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024636

Enrollment

Unknown

Registered

2019-07-19

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

FMT group:Intesinal microbiota transplantation

Control group:None

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Comply with the 2019 American Diabetes Association (ADA) diagnostic criteria for type 2 diabetes (T2DM); (2) Voluntary participation in the study and sign an informed consent form; (3) Regardless of gender, adult.

Exclusion criteria

Exclusion criteria: (1) Patients with acute and chronic infectious diseases, digestive tract diseases, cardiac insufficiency, liver and renal insufficiency; (2) Patients with gastrointestinal diseases that may affect drug absorption; (3) Pregnant and lactating women; (4) Allergic persons; (5) Patients treated with other hormones in the past three months; (6) Leukopenia or abnormal granulocytes; (7) Cardiovascular and cerebrovascular diseases within three months; (8) Those who participated in other clinical trials at the same time.

Design outcomes

Primary

Measure	Time frame
Blood glucose control;Insulin resistance;	—

Secondary

Measure	Time frame
Intestinal mircobiota sequencing;Immunological indicators;	—

Countries

China

Contacts

Public ContactHou Kaijian

Longhu Hospital, First Affiliated Hospital of Medical College of Shantou University

kaijianhou@126.com+86 13501400425

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026